Mathias Toft

Mathias Toft

Auto-generated profile, based on publicly available information

Mathias Toft

Department of Neurology, Oslo University Hospital

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
JKJennifer Kachergus
Jennifer Kachergus
IMIgnacio F. Mata
Ignacio F. Mata
MHMary Hulihan
Mary Hulihan
JTJulie P. Taylor
Julie P. Taylor
SLSarah Lincoln
Sarah Lincoln
MTMathias Toft
Mathias Toft

25 January 2006 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
OROwen A Ross
Owen A Ross
MTMathias Toft
Mathias Toft
AWAndrew J. Whittle
Andrew J. Whittle
JJJoseph L. Johnson
Joseph L. Johnson
SPSpiridon Papapetropoulos
Spiridon Papapetropoulos
DDDennis W. Dickson
Dennis W. Dickson

29 April 2015 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
CLChristina M. Lill
Christina M. Lill
ARAina Rengmark
Aina Rengmark
LPLasse Pihlstrøm
Lasse Pihlstrøm
IFIsabella Fogh
Isabella Fogh
ASAleksey Shatunov
Aleksey Shatunov
LBLars Bertram
Lars Bertram

25 April 2005 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
JAJan O. Aasly
Jan O. Aasly
MTMathias Toft
Mathias Toft
IFIgnacio Fernandez‐Mata
Ignacio Fernandez‐Mata
JKJennifer Kachergus
Jennifer Kachergus
MHMary Hulihan
Mary Hulihan
MFMatthew J. Farrer
Matthew J. Farrer

1 October 2004 in The American Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
LSLisa Skipper
Lisa Skipper
KWKristen Wilkes
Kristen Wilkes
MTMathias Toft
Mathias Toft
MBMatthew Baker
Matthew Baker
SLSarah Lincoln
Sarah Lincoln
MFMatthew J. Farrer
Matthew J. Farrer
The MAPT H1 haplotype has been associated with four-repeat (4R) tauopathies, including progressive supranuclear palsy, corticobasal degeneration, and argyrophilic grain disease. More controversial is that the same haplotype has been associated with Parkinson disease (PD). Using H1-specific single-nucleotide polymorphisms, we demonstrate that MAPT H1 is a misnomer and consists of a family of recombining H1 alleles. Population genetics, linkage disequilibrium, and association analyses have shown that specific MAPT H1 subhaplotypes are preferentially associated with Parkinson disease. Using a sliding scale of MAPT H1-specific haplotypes--in age/sex-matched PD cases and controls from central Norway--we have refined the disease association to within an approximately 90-kb interval of the 5' end of the MAPT locus.

14 August 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SBSilje Bjerknes
Silje Bjerknes
ISInger Marie Skogseid
Inger Marie Skogseid
TSTerje Sæhle
Terje Sæhle
EDEspen Dietrichs
Espen Dietrichs
MTMathias Toft
Mathias Toft
Deep brain stimulation (DBS) implant infection is a feared complication, as it is difficult to manage and leads to increased patient morbidity. We wanted to assess the frequency and possible risk factors of DBS related infections at our centre. In the purpose of evaluating treatment options, we also analyzed treatment, and the clinical and microbiological characteristics of the infections. Electronic medical records of all patients undergoing DBS surgery at our centre, from 2001 through 2010, were retrospectively reviewed. Of the 588 procedures performed 33 (5.6%) led to an infection. Some patients underwent several procedures, thus 32 out of totally 368 patients (8.7%), and 19 out of 285 patients (6.7%) who received primary lead implantation, developed an infection. Most infections (52%) developed within the first month and 79% within three months. In the majority of the infections (79%) hardware removal was performed. Staphylococcus aureus infections were the most frequent (36%), and more likely to have earlier onset, pus formation, a more aggressive development and lead to hardware removal. No risk factors were identified. Our results indicate that infections with more severe symptoms and growth of staphylococcus aureus should be treated with local hardware removal and antibiotic therapy. In other infections, an initial trial of antibiotic treatment could be considered. New knowledge about the microbiology of DBS related infections may lead to more effective antimicrobial treatment.